Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trialÉric Baudin, Anouk van Berkel, Alfredo Berruti et al.|The Lancet|2024Cited by 69